All In Biotech

Drug Trial Radar · NCT05279846

A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

A Multi-center, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)

Last checked: Nov 19, 2026Latest source record: Jun 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 350 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

350

Planned (sponsor's estimate)

Start

May 9, 2022

Primary completion

Jan 2025

Study completion Jan 2025

Sponsor

Lead sponsor
Moberg Pharma ABIndustry
Sponsor type
Industry
First posted
Mar 15, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3 multicenter, double-blind study to evaluate the safety and efficacy of vehicle-controlled topical MOB015B in the treatment of Distal Subungual Onychomycosis (DSO)

Conditions

  • Onychomycosis

Interventions

  • MOB015BDrug

    Applied topically for 48 weeks

  • Vehicle (Placebo Comparator)Drug

    Applied topically for 48 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects with complete cure of the target toenailTime frame: 52 Week
  2. Incidence of adverse events (Safety)Time frame: 52 Week

Locations

35 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama Hospital

    Birmingham, Alabama

  • California Dermatology & Clinical Research Institute

    Encinitas, California

  • Center for Dermatology Clinical Research,Inc

    Fremont, California

  • Dermatology Research Associates

    Los Angeles, California

  • Center for Clinical Research

    San Francisco, California

  • Colorado Medical Research Center

    Denver, Colorado

  • Olympian Clinical Research

    Clearwater, Florida

  • Driven Research LLC

    Coral Gables, Florida

  • Doctors Research Institute Corporation

    South Miami, Florida

  • Podiatry 1st

    O'Fallon, Illinois

  • The South Bend Clinic, LLC

    South Bend, Indiana

  • DelRicht Research - Baton Rouge

    Baton Rouge, Louisiana

  • IMA Clinical Research

    Monroe, Louisiana

  • David Fivenson, MD, Dermatology, PLLC

    Ann Arbor, Michigan

  • Michigan Center for Skin Care Research

    Clinton Township, Michigan

  • Associated Skin Care Specs

    New Brighton, Minnesota

  • Skin Specialists, PC

    Omaha, Nebraska

  • Hassman Research Institute

    Berlin, New Jersey

  • Forest Hills Dermatology Group

    Kew Gardens, New York

  • Weill Cornell Medicine Dermatology

    New York, New York

  • Skin Search of Rochester

    Rochester, New York

  • UNC Dermatology and Skin Cancer Center

    Chapel Hill, North Carolina

  • Haber Dermatology, Inc.

    Beachwood, Ohio

  • Oregon Dermatology and Research Center

    Portland, Oregon

  • UPMC Department of Dermatology

    Pittsburgh, Pennsylvania

  • Martin Foot and Ankle

    York, Pennsylvania

  • Coastal Carolina Research Center

    North Charleston, South Carolina

  • Tennessee Clinical Research Center

    Nashville, Tennessee

  • DermResearch, Inc.

    Austin, Texas

  • Futuro Clinical Trials LLC

    McAllen, Texas

  • Progressive Clinical Research, PA

    San Antonio, Texas

  • Houston Center for Clinical Research

    Sugar Land, Texas

  • Virginia Clinical Research, Inc.

    Norfolk, Virginia

  • Mediprobe Research

    London, Ontario, Canada

  • Toronto Research Centre

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.